Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy-Reference-Cited by-同舟云学术

Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy

Published:2017-08 Issue: Volume:104 Page:85-96
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

El-Agnaf Omar,Overk Cassia,Rockenstein Edward,Mante Michael,Florio Jazmin,Adame Anthony,Vaikath Nishant,Majbour Nour,Lee Seung-Jae,Kim Changyoun,Masliah Eliezer,Rissman Robert A.

Funder

NIH

Publisher

Elsevier BV

Subject

Neurology

Reference67 articles.

1. Antibody-aided clearance of extracellular alpha-synuclein prevents cell-to-cell aggregate transmission;Bae;J. Neurosci.,2012

2. Glucocerebrosidase depletion enhances cell-to-cell transmission of alpha-synuclein;Bae;Nat. Commun.,2014

3. Alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation;Bartels;Nature,2011

4. From alpha-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease;Bellucci;Brain Res.,2012

5. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease;Conway;Nat. Med.,1998

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes;Cell Biochemistry and Function;2024-08-27

2. Quantitative systems pharmacology model of α‐synuclein pathology in Parkinson's disease‐like mouse for investigation of passive immunotherapy mechanisms;CPT: Pharmacometrics & Systems Pharmacology;2024-08-23

3. The Role of Astrocytes and Alpha-Synuclein in Parkinson’s Disease: A Review;NeuroSci;2024-03-08

4. α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes;Translational Neurodegeneration;2024-02-21

5. Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease;Advanced Materials;2023-10-27